Minjung Sung
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Correction: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer.
Journal: Breast cancer research : BCR
Published: January 08, 2025
Real-time assessment of relative mitochondrial ATP synthesis response against inhibiting and stimulating substrates (MitoRAISE).
Journal: Cancer & metabolism
Published: April 09, 2024
Detection of EGFR exon 20 insertion mutations in non-small cell lung cancer: implications for consistent nomenclature in precision medicine.
Journal: Pathology
Published: October 06, 2023
c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer.
Journal: Breast cancer research : BCR
Published: May 30, 2023
Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma.
Journal: Cancer research and treatment
Published: July 01, 2022
NTRK Fusions in 1113 Solid Tumors in a Single Institution.
Journal: Diagnostics (Basel, Switzerland)
Published: May 16, 2022
Analysis of PIK3CA Mutation Concordance and Frequency in Primary and Different Distant Metastatic Sites in Breast Cancer.
Journal: Cancer research and treatment
Published: January 02, 2022
TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis.
Journal: Cancer research and treatment
Published: May 10, 2020
Association with PD-L1 Expression and Clinicopathological Features in 1000 Lung Cancers: A Large Single-Institution Study of Surgically Resected Lung Cancers with a High Prevalence of EGFR Mutation.
Journal: International journal of molecular sciences
Published: August 31, 2019
Molecular changes in solitary fibrous tumor progression.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: February 06, 2019
Status of programmed death-ligand 1 expression in sarcomas.
Journal: Journal of translational medicine
Published: May 27, 2018
Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer.
Journal: Cancer biology & therapy
Published: January 16, 2018
Last Updated: 09/26/2026